Press release
Homocystinuria Treatment Market Expands with Orphan Drug Approvals in the U.S. & Japan | Travere Therapeutics, Aeglea BioTherapeutics, Ginkgo Bioworks
Homocystinuria Market
Homocystinuria Market Report by DataM Intelligence offers a detailed assessment of the global metabolic-disorders landscape, highlighting market size, key players, and critical growth drivers. With newborn screening expansion, enzyme-replacement and replacement cofactor strategies, and gene-therapy R&D, the report delivers strategic insights for stakeholders from 2025 to 2033. In 2025, the sector saw a notable pause in a Phase-III pegtibatinase trial (HARMONY) while sponsors recalibrate development plans, and new U.S. cost-utilization studies clarified the long-term healthcare burden both developments shaping near-term commercialization timelines.
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/homocystinuria-market?ophp
Homocystinuria Market Competitors Overview:
Travere Therapeutics, Aeglea BioTherapeutics, Ginkgo Bioworks, Cosette Pharmaceuticals, Inc., Eton Pharmaceuticals, Inc., and Others.
Important Industry Updates:
In May 2023, Eton Pharmaceuticals, Inc, a pharmaceutical company engaged in developing and commercializing treatments for rare diseases, reported the commercial availability of Betaine Anhydrous for Oral Solution 180 grams for the treatment of homocystinuria.
Methodology and Scope
The Homocystinuria Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/homocystinuria-market?ophp
Homocystinuria Market Segments Overview:
By Drug Treatment (Pyridoxine, Betaine, Folate, Cobalamin), By Form (Tablets, Suspension, Pills, Capsules), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
Regional Overview for Homocystinuria Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=homocystinuria-market
The Report Covers:
➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.
People Also Ask:
➤ What are the current global trends in sales, production, imports, and exports within the Homocystinuria market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Homocystinuria market?
Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Homocystinuria Treatment Market Expands with Orphan Drug Approvals in the U.S. & Japan | Travere Therapeutics, Aeglea BioTherapeutics, Ginkgo Bioworks here
News-ID: 4142692 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Lab-on-a-Chip Market to Reach US$ 14.66 Billion by 2032 | CAGR 10.12% | North Am …
Lab-on-a-Chip Market Overview
The global Lab-on-a-Chip (LoC) market reached US$ 6.78 billion in 2024 and is projected to reach US$ 14.66 billion by 2032, growing at a CAGR of 10.12% during the forecast period (2025-2032). The market growth is primarily driven by the rising demand for quick, portable, and cost-effective diagnostic solutions in medical, pharmaceutical, and research sectors. Lab-on-a-chip devices integrate multiple laboratory functions onto a single microchip, enabling real-time disease…
Network Security Sandbox Market to Reach US$ 368.48 Billion by 2032 | CAGR 53.46 …
Network Security Sandbox Market Overview
The global Network Security Sandbox (NSS) Market reached US$ 11.98 billion in 2024 and is projected to surge to US$ 368.48 billion by 2032, growing at a remarkable CAGR of 53.46% during the forecast period 2025-2032. The rapid expansion is driven by the rising prevalence of cyber threats worldwide, including advanced persistent threats (APTs), zero-day attacks, ransomware, phishing, and malware, which are often undetected by traditional…
AI in Edge Computing Market to Reach US$ 83.86 Billion by 2032 | CAGR 22.5% | No …
AI in Edge Computing Market Overview
The global AI in Edge Computing market reached US$ 16.54 billion in 2024 and is projected to grow to US$ 83.86 billion by 2032, expanding at a CAGR of 22.50% during the forecast period 2025-2032.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/ai-in-edge-computing-market?Juli
The market is witnessing rapid growth, driven by the increasing demand for real-time data processing, low-latency applications,…
Kidney Transplant Market to Reach US$ 10.99 Billion by 2033 | CAGR 3.7% | North …
Kidney Transplant Market
The global kidney transplant market reached US$ 7.91 billion in 2024 and is projected to grow to US$ 10.99 billion by 2033, registering a CAGR of 3.7% during the forecast period 2025-2033.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/kidney-transplant-market?Juli
The market growth is primarily driven by the rising prevalence of end-stage renal disease (ESRD) and chronic kidney disorders worldwide. Advances in…
More Releases for Homocystinuria
Homocystinuria Market to Reach USD 1.76 Billion by 2034
Pune, India - December 2025 - The global Homocystinuria Market, valued at USD 1.01 billion in 2024, is projected to reach USD 1.76 billion by 2034, growing at a 5.7% CAGR (2025-2034), according to Exactitude Consultancy. Rising adoption of newborn screening programs, improved diagnostic accuracy, and the development of targeted metabolic therapies are key factors driving market growth.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72025
Market Summary
The Homocystinuria Market…
Homocystinuria Market to Reach USD 1.5 Billion by 2034
Homocystinuria is a rare inherited metabolic disorder caused by a deficiency of enzymes involved in the metabolism of the amino acid methionine, most commonly cystathionine beta-synthase (CBS). This results in elevated levels of homocysteine and its metabolites in blood and urine, leading to multisystem complications including skeletal abnormalities, intellectual disability, vascular disease, and ocular problems such as lens dislocation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72025
Although the disease…
Homocystinuria Market Growth, Trends & Forecast 2025 | Leading key players - Tra …
The Global Homocystinuria Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.
Homocystinuria Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough…
Homocystinuria Market: Projected Positive Growth Trends through 2024-2031 - Trav …
The Homocystinuria Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/homocystinuria-market
What is the projected growth…
Homocystinuria Market Size, Share, Trends Analysis And Forecast 2024-2033
Market Definition
Homocystinuria is an inherited metabolic disorder caused by the body's inability to break down an amino acid called homocysteine. It is a rare condition, affecting approximately one in every 100,000 to 200,000 people worldwide.
Market Outlook
When homocysteine is not broken down properly, it accumulates in the blood and causes a variety of health problems. Those affected by homocystinuria are unable to convert the essential amino acid methionine to cysteine, which…
Managing Homocystinuria: A Decade Forecast for the Market (2023-2033)
Market Outlook:
The Homocystinuria Market envisions a decade of balanced health with a positive outlook from 2023 to 2033. As awareness of rare genetic disorders grows and advancements in medical research continue, the market anticipates significant progress in addressing Homocystinuria. This transformative period is characterized by factors such as increasing diagnostic capabilities, the evolution of targeted therapies, and ongoing efforts to improve patient outcomes. The forecast marks a decade of opportunities…
